Be in the know. 20 key reads for Monday…

  1. Stock Market Soars on FDA News (Barron’s)
  2. Market timing when ‘clocks have no hands’ — Warren Buffett’s warning is as relevant now as it was in 2000 (MarketWatch)
  3. M&A Was Dead. Why It’s Come Roaring Back. (Barron’s)
  4. AstraZeneca stock climbs on reports Trump considering fast-tracking COVID-19 vaccine (MarketWatch)
  5. Antibody Drugs Advancing to Fill Covid-19 Treatment Gap (Wall Street Journal)
  6. Why Steve Cohen’s SEC history shouldn’t hurt his Mets bid (New York Post)
  7. Blackstone Gains $5 Billion on Cheniere LNG Stake (Bloomberg)
  8. China’s Vaccine Front-Runner Aims to Beat Covid the Old-Fashioned Way (Bloomberg)
  9. These areas of the cyclical trade are set to outperform, $114 billion money manager says (CNBC)
  10. Opinion: These 15 stocks are ready to ride the bull market’s next leg up (MarketWatch)
  11. Russell Crowe’s ‘Unhinged’ off to a decent start as U.S. theaters slowly reopen (CNBC)
  12. What Is Covid-19 Convalescent Plasma? (Wall Street Journal)
  13. Intel (INTC) Initiates $10 Billion Accelerated Share Repurchase Agreements (StreetInsider)
  14. 5 Blue Chip Stocks to Buy Now That Pay a 6% or Higher Dividend (24/7 Wall Street)
  15. ‘Opportunity zones’ drew $75B in private investment in 2 years, White House says (Fox Business)
  16. Municipality of Lucknow in UP India Now Distributes Free Ivermectin via Kiosks to Treat COVID-19 (TrialSiteNews)
  17. S&P 500, Nasdaq set to hit new highs on COVID-19 treatment hopes (Reuters)
  18. This Market Is a Tech Market. If Bond Yields Rise, Watch Out. (Wall Street Journal)
  19. The Lionel Richie “Dancing on the Ceiling” Stock Market (and Sentiment Results)… (ZeroHedge)
  20. Schwarzman’s Blackstone buys Japanese drugs subsidiary (Fox Business)